Articles that mention Pascal Soriot -BoardProspects

Pascal Soriot

0 Comments Leave a Comment

1-11 of 11
1. Mentioned In 11 Articles
2. We’re All The Poorer for Shareholders’ Loss of Nerve on Executive Pay
  
  Explore msn.com May 16 2021 BoardBlogs
  
  ...meetings. The board of AstraZeneca asked shareholders to support their decision to award the chief executive, Pascal Soriot, £18m in annual pay and perks. Despite strong shows of dissent, from shareholder advisory groups...
  Read Full Article
  
  Comment
  
  Mentions: Investment Sky AstraZeneca
3. AstraZeneca CEO £2.3m Bonus Hike Sparks Shareholder Row
  
  Explore Yahoo! Finance May 9 2021 BoardNews
  
  ...OVID-19 vaccine, the company's CEO is facing pushback from shareholders over a potential big bump in bonuses. Pascal Soriot is in line for a windfall of between £2.3m ($3.2m) and £12m — a sum that could rise in line with...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management ISS
4. ‘Obscene’ Bonus Hike for AstraZeneca Boss Prompts Investor Anger
  
  Explore msn.com May 4 2021 BoardNews
  
  ... against the policy... AstraZeneca is facing mounting opposition over its plans to award its chief executive, Pascal Soriot, a big increase in bonuses, with two investor advisory groups calling on shareholders to vote ag...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management ISS
5. Astra Plots Post-Covid Future With $39 Billion Alexion Deal
  
  Explore msn.com Dec 12 2020 BoardNews
  
  ...rtfolio of Cambridge, U.K.-based AstraZeneca, which had spent years paring away older and less profitable ... Pascal Soriot The purchase is “an important step in the history of the company,” Soriot said on a call with re...
  Read Full Article
  
  Comment
  
  Mentions: Management Goldman Sachs CFO
6. 20 Highest-Paid Biopharma CEOs
  
  Explore Pharma News Sep 18 2020 BoardNews
  
  ...op-paid CEOs list. A collection of Big Pharma chiefs stay off that list year after year. AstraZeneca's ($AZN) Pascal Soriot, for instance. GlaxoSmithKline's ($GSK) Andrew Witty. And this year, both Joe Jimenez of Novarti...
  Read Full Article
  
  Comment
  
  Mentions: Twitter stock options Vertex
7. AstraZeneca Plots Search for Next Chairman
  
  Explore Yahoo! UK & Ireland Finance Jun 3 2019 BoardNews
  
  ...number of the Anglo-Swedish group's leading shareholders because, unusually, Mr Johansson and chief executive Pascal Soriot took on their roles within four months of each other. While a definitive decision about which of...
  Read Full Article
  
  Comment
  
  Mentions: Takeover Bid Succession CFO
8. Could Proxy Advisers Sway Investors to Vote ‘No’ on BMS-Celgene Merger?
  
  Explore Pharma News Mar 21 2019 BoardBlogs
  
  ...er opinion. Last year, ISS urged AstraZeneca shareholders to vote against the company’s planned bonus for CEO Pascal Soriot. That was enough to convince 35% of shareholders to vote against it or abstain—a significant rev...
  Read Full Article
  
  Comment
  
  Mentions: Management ISS acquisition
9. Lilly CEO David Ricks Snags $17.2M Pay Package for 2018, a 9% Hike
  
  Explore Pharma News Mar 13 2019 BoardNews
  
  ...lems of its own, paid its helmsman Olivier Brandicourt $8.2 million last year, a 25% decline. AstraZeneca CEO Pascal Soriot's pay climbed to nearly $15 million, and new Novartis helmsman Vas Narasimhan earned a pay packa...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi stock options David Ricks
10. AstraZeneca Pays CEO Soriot Nearly $15M After 2018's Return to Growth. Will Investors Push Back?
  
  Explore Pharma News Mar 5 2019 BoardNews
  
  ...Pascal Soriot's 11.36 million ($14.93 million) in total pay last year, a 9% jump from 2017... AstraZeneca CEO Pascal Soriot bemoans being one of the 'lowest-paid' CEOs in pharma If AZ investors have issues with Soriot's ...
  Read Full Article
  
  Comment
  
  Mentions: stock options AstraZeneca Pascal Soriot
11. Despite 34% Cut, AstraZeneca Shareholders Still Don't Like CEO Soriot's £9.4M Pay
  
  Explore Pharma News May 21 2018 BoardNews
  
  ...t has made at investors’ request. AstraZeneca has faced compensation complaints for years now, ever since CEO Pascal Soriot’s arrival came with a signing bonus designed to take the place of payouts he expected from his p...
  Read Full Article
  
  Comment
  
  Mentions: hostile takeover ISS stock options
12. It's Another Dust-Up Over AstraZeneca's CEO Pay, This Time Focused on His Bonus
  
  Explore Pharma News May 8 2018 BoardBlogs
  
  ...tive costs by this year and focus on key pipeline projects. RELATED: AstraZeneca investors rebel—again—at CEO Pascal Soriot's 68% bonus-pay boost Soriot’s efforts did pay off for shareholders last year to some extent. Th...
  Read Full Article
  
  Comment
  
  Mentions: ISS stock options AstraZeneca
13. 1-11 of 11